Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium; Division of Gynaecological Oncology, Leuven Cancer Institute, Kuleuven, Herestraat 49, 3000 Leuven, Belgium.
Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Belgium; Center for Cancer Biology, VIB, Herestraat 49, bus 912, 3000 Leuven, Belgium.
Gynecol Oncol. 2018 Oct;151(1):61-68. doi: 10.1016/j.ygyno.2018.08.013. Epub 2018 Aug 28.
Ovarian germ cell tumors (OGCT) are rare gynecological neoplasms, mostly affecting children and young women. The underlying molecular genetic background of these tumors is poorly characterized.
We analyzed somatic copy number aberration (CNA) profiles in 87 OGCT tumors and performed whole exome sequencing (WES) on 24 OGCT tumor and matched germline samples to further elucidate their molecular genetic landscape.
The overall mutation rate was very low in OGCT compared to other human cancers, with an average of 0.05 mutations per Mb, consistent with their embryological origin. We identified recurrent mutations in KIT and KRAS, while CNA profiling revealed frequent focal amplifications affecting PIK3CA and AKT1 in yolk sac tumors, recurrent focal deletions affecting chromosomal regions 1p36.32, 2q11.1, 4q28.1, 5p15.33, 5q11.1 and 6q27, as well as gains in chromosome 12p that were present in all tumors, except for pure immature teratomas.
We here present the first whole exome sequencing data and to our knowledge the largest CNA study in OGCT. We confirmed that earlier reported KIT mutations were frequent in dysgerminomas and mixed forms with a dysgerminoma component, whereas chromosome 12p gains were present in all histological subtypes except pure immature teratomas. We detected recurrent KRAS mutations, recurrent focal deletions and an enrichment in the PI3K/AKT/PTEN pathway in yolk sac tumors. Several of these aberrations involve targetable pathways, offering novel treatment modalities for OGCT.
卵巢生殖细胞肿瘤(OGCT)是罕见的妇科肿瘤,主要影响儿童和年轻女性。这些肿瘤的潜在分子遗传学背景尚未得到充分描述。
我们分析了 87 例 OGCT 肿瘤的体细胞拷贝数异常(CNA)谱,并对 24 例 OGCT 肿瘤和匹配的种系样本进行了全外显子组测序(WES),以进一步阐明其分子遗传学特征。
OGCT 的总体突变率与其他人类癌症相比非常低,平均每 Mb 有 0.05 个突变,与它们的胚胎起源一致。我们鉴定了 KIT 和 KRAS 的高频突变,而 CNA 谱分析显示,在卵黄囊瘤中频繁出现影响 PIK3CA 和 AKT1 的局灶性扩增,在所有肿瘤中都存在的 1p36.32、2q11.1、4q28.1、5p15.33、5q11.1 和 6q27 染色体区域的反复出现的局灶性缺失,以及 12p 染色体的增益,但纯未成熟畸胎瘤除外。
我们在此首次提供了 OGCT 的全外显子组测序数据和据我们所知最大的 CNA 研究。我们证实,以前报道的 KIT 突变在卵黄囊瘤和具有卵黄囊瘤成分的混合形式中较为常见,而 12p 染色体的增益存在于所有组织学亚型中,除了纯未成熟畸胎瘤。我们检测到卵黄囊瘤中 KRAS 高频突变、局灶性缺失和 PI3K/AKT/PTEN 通路的富集。这些异常中的一些涉及可靶向的途径,为 OGCT 提供了新的治疗方法。